CellSeedCellSeed Inc.7776東証グロース精密機器FY ending Dec 2025, non-consolidated, J-GAAP
About 58% of CellSeed's sales come from Cell-Sheet regenerative medicine, with Laboratory consumables and equipment making up much of the rest.
It lost about ¥283 for every ¥100 of sales at the operating level.
For every ¥100 CellSeed sells, how much goes where, and how much is kept.
Margin funnel (derived from reported values)Gross margin 78.5% → Operating margin -283.1% → Net margin -283.7%
Revenue by business segment, and the profit each one keeps.
※ Segment figures include inter-segment sales and do not sum to the company total
Spotted an error? Report it (corrections keep the original record)
Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.